Clinical Trials Directory

Trials / Completed

CompletedNCT03110393

Ambu®AuraGain™ Versus I-gel® in Obese Patients

Prospective Randomized Comparison Between a Fiber Optic Intubation Via the Ambu® AuraGain ™ or the i-Gel® Laryngeal Mask Until a Complete Airway Protection in Obese Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Schulthess Klinik · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of this study is the randomized comparison of two laryngeal mask (Intersurgical i-gel® and Ambu®AuraGain™) in obese patients

Detailed description

Since the incidence of a difficult intubation lies between 4.5% -7.5%, the search for alternative airway devices has been forced in the past. As an option, the laryngeal mask is suitable, which has been used as a universal airway with a high degree of safety in routine anesthesia. There are numbers of different laryngeal masks available which have the characteristic to insert an endotracheal tube through the ventilation lumen. The indications for these laryngeal masks can be extended due to continuous improvements in the laryngeal masks, these laryngeal masks can also be used in obese patients. Obese patients generally have a 4-fold increased risk of a difficult airway, and a BMI over 35 is a predictor of a difficult tracheal intubation. There are no studies comparing the Intersurgical i-gel® Laryngeal Mask and the Ambu®AuraGain ™ Laryngeal Mask in obese patients.

Conditions

Interventions

TypeNameDescription
DEVICEAmbu AuraGainInsert and intubation of an Ambu® AuraGain™ laryngeal mask
DEVICEIntersurgical i-gelInsert and intubation of an Intersurgical i-gel®

Timeline

Start date
2017-04-20
Primary completion
2017-09-06
Completion
2017-09-06
First posted
2017-04-12
Last updated
2018-01-08

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03110393. Inclusion in this directory is not an endorsement.